Canaccord Reiterates Buy Rating on AtriCure Inc. (ATRC)

June 30, 2026 6:51 AM

Canaccord analyst William Plovanic reiterated a Buy rating and $55.00 price target on AtriCure ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found